Publications

Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa.

Hippner, P; SUMNER, T; HOUBEN, RM; Cardenas, V; VASSALL, A; BOZZANI, F; Mudzengi, D; Mvusi, L; Churchyard, G; WHITE, RG;

2019

PloS one, (2019).14 1 10.1371/journal.pone.0209320.

Analysis of cellular and soluble profiles in QuantiFERON nonconverters, converters, and reverters in the Gambia.

Medawar, L; Tukiman, HM; Mbayo, G; Donkor, S; Owolabi, O; SUTHERLAND, JS;

2019

Immunity, inflammation and disease, (2019).7 4 10.1002/iid3.269.

TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol.

Rachow, A; Ivanova, O; Wallis, R; Charalambous, S; Jani, I; Bhatt, N; KAMPMANN, B; SUTHERLAND, J; Ntinginya, NE; Evans, D; Lönnroth, K; Niemann, S; Schaible, UE; Geldmacher, C; Sanne, I; Hoelscher, M; Churchyard, G;

2019

BMC PULMONARY MEDICINE, (2019).19 1 10.1186/s12890-018-0777-3.

Changes in Transcript, Metabolite, and Antibody Reactivity During the Early Protective Immune Response in Humans to Mycobacterium tuberculosis Infection.

Weiner, J; Domaszewska, T; Donkor, S; Kaufmann, SH E; Hill, PC; SUTHERLAND, JS;

2019

Clinical infectious diseases, (2019).71 1 10.1093/cid/ciz785.

Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.

HARRIS, RC; SUMNER, T; KNIGHT, GM; Evans, T; Cardenas, V; Chen, C; WHITE, RG;

2019

The Lancet Global Health, (2019).7 2 10.1016/S2214-109X(18)30452-2.

The landscape of diagnostic mycobacteriology in Germany-challenges of decentralised care.

Maurer, FP; Mintken, E; Rupp, J; OLARU, I; KRANZER, K;

2019

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, (2019).23 8 10.5588/ijtld.18.0763.

Changes in Mycobacterium tuberculosis-Specific Immunity With Influenza co-infection at Time of TB Diagnosis.

Mendy, J; JARJU, S; Heslop, R; Bojang, AL; KAMPMANN, B; SUTHERLAND, JS;

2019

FRONTIERS IN IMMUNOLOGY, (2019).9 JAN 10.3389/fimmu.2018.03093.

Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy.

SUMNER, T; Scriba, TJ; Penn-Nicholson, A; Hatherill, M; WHITE, RG;

2019

Scientific Reports, (2019).9 1 10.1038/s41598-019-47645-z.

TB Fast Track: a study to evaluate the effect of a point-of-care TB test-and-treat algorithm on early mortality in people with HIV accessing ART, a trial with randomisation at clinic level.

FIELDING, K; Charalambous, S; Hoffmann, CJ; Johnson, S; Tlali, M; Dorman, SE; VASSALL, A; Churchyard, GJ; GRANT, AD;

2019

, London School of Hygiene & Tropical Medicine (2019). 10.17037/PUBS.04653158.